Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice - Laboratoire Génomique, bioinformatique et chimie moléculaire Accéder directement au contenu
Article Dans Une Revue Vaccines Année : 2024

Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice

Résumé

The COVID-19 pandemic has raised the standard regarding the current vaccine development pace, as several messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccines have proved their ability to induce strong immunogenicity and protective efficacy. We developed 1-methylpseudouridine-containing mRNA-LNP vaccines, expressing either the more conserved SARS-CoV-2 nucleoprotein (mRNA-N) or spike protein (mRNA-S), both based on the prototypic viral sequences. When combining both mRNA-S and mRNA-N together (mRNA-S+N), the vaccine showed high immunogenicity and broad protection against different SARS-CoV-2 variants, including wildtype, Delta, BA.1, BA.5, and BQ.1. To better understand the mechanisms behind this broad protection obtained by mRNA-S+N, we analyzed innate and adaptive immune parameters following vaccination in mice. Compared to either mRNA-S or mRNA-N alone, mice vaccinated with mRNA-S+N exhibited an increase in the innate immune response, as depicted by the higher cytokine (IL-6 and chemokine (MCP-1) levels. In addition, lymph node immunophenotyping showed the maturation and activation of dendritic cells and natural killer cells, respectively. To understand the adaptive immune response, RNA-Seq analyses of the lung and spleen samples of the vaccinated mice were performed in parallel and revealed a stronger immune gene-expression profile in the lung than that in the spleen. Compared to mRNA-S alone, mRNA-S+N vaccination elicited higher levels of expression for genes involved in multiple immune pathways, including T cells, cytokine signaling, antigen presentation, B cells, and innate immunity. Together, our studies provide immunological insights into the mechanisms of broad protection conferred by dual mRNA vaccination against SARS-CoV-2 variants.
Fichier principal
Vignette du fichier
vaccines-12-00543.pdf (1.34 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence

Dates et versions

hal-04600304 , version 1 (04-06-2024)

Licence

Identifiants

Citer

Srinivasa Reddy Bonam, Nicholas Hazell, Mano Joseph Mathew, Yuejin Liang, Xuxiang Zhang, et al.. Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice. Vaccines, 2024, 12 (5), pp.543. ⟨10.3390/vaccines12050543⟩. ⟨hal-04600304⟩
15 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More